Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07203976

Visual and Refractive Outcomes Following Stream Light Photorefractive Keratectomy (55μm Epithelial Removal) Versus Conventional Photorefractive Keratectomy

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Photorefractive keratectomy (PRK) is a well-established corneal refractive surgery that involves epithelial removal followed by stromal ablation to correct myopia, hyperopia, and astigmatism. The method of epithelial removal in PRK significantly impacts healing, pain levels, and visual outcomes. Trans-epithelial PRK (StreamLight) performed on the EX500 excimer laser platform removes the epithelium and reshapes the corneal stroma in a single laser-guided step, potentially reducing tissue manipulation and enhancing epithelial healing. In contrast, manual epithelial removal PRK involves mechanical debridement, with epithelial removal depth being manually controlled. The variability of epithelial thickness in StreamLight PRK may influence visual outcomes, whereas in manual PRK, a fixed epithelial removal depth of 55 microns provides a standardized approach.

Detailed description

This study aimed to compare the visual and refractive outcomes of StreamLight PRK versus manual PRK with fixed epithelial removal. Type of the study: Retrospective cross-sectional study * Study Setting: Alforsan Eye Centre * Study subjects: a. Inclusion criteria: * Patients aged 18-40 years. * Myopia up to -6.00 D and astigmatism up to -3.00 D. * Stable refraction for at least one year. * No history of ocular surgery or corneal pathology. b. Exclusion criteria: * Presence of keratoconus or suspected corneal ectasia. * Severe dry eye disease or significant ocular surface disease. * History of autoimmune disease or systemic conditions affecting wound healing. * Prior herpetic eye disease. c. Sample Size Calculation: A sample size calculation will be performed to ensure adequate statistical power. Anticipated enrollment: \[e.g., 50 eyes per group\] based on previous PRK outcome studies (Marshall et al., 2018). * Study tools (in detail, e.g., lab methods, instruments,steps, chemicals, …): * Alcon Wavelight EX500 excimer laser (Alcon Laboratories, Fort Worth, TX, USA) * Wavelight Oculyzer II Am Wolfsmantel 5, Erlangen, Germany * Autorefractor KR-8900 (Topcon, Tokyo, Japan)

Conditions

Timeline

Start date
2025-05-03
Primary completion
2026-02-01
Completion
2026-05-01
First posted
2025-10-02
Last updated
2025-10-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07203976. Inclusion in this directory is not an endorsement.